FDA Adverse Event Malfunction Summary report: N

TEMPORARY NON-ROLLER TYPE RIGHT HEART SUPPORT BLOOD PUMP

MDR report key: 25067507 · Received May 4, 2026

Report

Report Number
1220648-2026-07383
Event Type
Malfunction
Date Received
May 4, 2026
Date of Event
April 26, 2026
Manufacturer
ABIOMED, INC. - 1220648
Product Code
PYX
UDI-DI
04260113630273
PMA / PMN Number
P170011
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE ISSUE WAS SOLVED AND THE PATIENT RECOVERED. THE PUMP WAS EXPLANTED, BUT UNFORTUNATELY THROWN AWAY, SO IT IS NOT AVAILABLE FOR RETURN. THE DEVICE WAS NOT REMOVED BECAUSE OF THE COMPLAINT. THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY ABIOMED INC, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, ABIOMED INC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 0

CLINICAL NARRATIVE: AN IMPELLA RP DEVICE WAS INSERTED VIA THE LEFT FEMORAL VEIN IN A 31-YEAR-OLD MALE PATIENT PRESENTING WITH ACUTE MYOCARDIAL INFARCTION COMPLICATED BY CARDIOGENIC SHOCK (AMI/CGS). THE PATIENT¿S COMORBIDITIES WERE UNKNOWN. THE PATIENT¿S CLINICAL STATE PRIOR TO INITIATION OF SUPPORT WAS IDENTIFIED AS SCAI SHOCK STAGE E. DURING SUPPORT, THE REGISTERED NURSE OBSERVED DECREASING PURGE FLOW FROM 5.5 ML/H AND PURGE PRESSURE OF 584 MMHG IN THE MORNING TO 2.9 ML/H AND PURGE PRESSURE OF 860 MMHG LATER IN THE DAY. THERE WAS NO INCREASE IN MOTOR CURRENT, NO ALARMS, AND THE PUMP WAS FUNCTIONING WELL. THE LAST PARTIAL THROMBOPLASTIN TIME (PTT) WAS 41 SECONDS, AND THE HEPARIN DOSE HAD ALREADY BEEN INCREASED. THE CASE WAS DISCUSSED AND RECOMMENDATIONS WERE GIVEN, INCLUDING POINTING OUT RISKS AND WHAT TO OBSERVE. THE TEAM WANTED TO INITIATE TPA-PURGE-LYSIS, AND THE PROTOCOL WAS SENT VIA EMAIL. TISSUE PLASMINOGEN ACTIVATOR (TPA) WAS UTILIZED FOR HIGH PURGE PRESSURE TO MITIGATE THE IMPACT OF BIOMATERIAL WITHIN THE MOTOR, AND THERE WAS NO IMPACT ON THE PATIENT. THE PATIENT SURVIVED TO EXPLANT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
593855 TEMPORARY NON-ROLLER TYPE RIGHT HEART SUPPORT BLOOD PUMP PYX ABIOMED, INC. - 1220648 2026815316 04260113630273

Patients

Seq Age Sex Outcome Treatment
1